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A treatment regime maps observed patient characteristics to a recommended treatment. Recent technological
advances have increased the quality, accessibility, and volume of patient-level data; consequently, there is a growing
need for powerful and flexible estimators of an optimal treatment regime that can be used with either observational
or randomized clinical trial data. We propose a novel and general framework that transforms the problem of esti-
mating an optimal treatment regime into a classification problem wherein the optimal classifier corresponds to the
optimal treatment regime. We show that commonly employed parametric and semi-parametric regression estima-
tors, as well as recently proposed robust estimators of an optimal treatment regime can be represented as special
cases within our framework. Furthermore, our approach allows any classification procedure that can accommodate
case weights to be used without modification to estimate an optimal treatment regime. This introduces a wealth
of new and powerful learning algorithms for use in estimating treatment regimes. We illustrate our approach using
data from a breast cancer clinical trial. Copyright © 2012 John Wiley & Sons, Ltd.
Keywords: classification; doubly robust estimator; inverse probability weighting; personalized medicine; potential
outcomes; propensity score
1 Introduction
The goal of personalized medicine is to inform clinical interventions using individual patient characteristics. These
characteristics may include patient demographics, genetic or genomic information, treatment and outcome history,
ability to cope with side-effect burden, and so on. Personalized medicine has the potential to increase the quality
of patient care while reducing cost by reducing over-treatment and making efficient use of all existing informa-
tion. There is currently a great deal of interest among clinical and intervention scientists in the development of
evidence-based personalized treatment strategies, also known as treatment regimes. With the increasing volume,
accessibility, and quality of patient level data, statistics has an important role to play in the estimation and evaluation of
treatment regimes.
Formally, a treatment regime is a rule that assigns a treatment, from among a set of possible treatments, to a patient
based on his/her observed characteristics. Deducing optimal treatment regimes using data from a clinical trial or
observational study can be informed, for example, in traditional regression-based methods, by identifying patient
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covariates that exhibit a qualitative interaction with treatment assignment; i.e., an interaction in which the treatment
effect changes direction depending on the covariates (Gunter et al., 2011).
Recently, there has been vigorous research on estimating optimal treatment regimes involving a single decision
or a series of decisions based on data from clinical trials or observational studies (Murphy, 2003; Robins, 2004;
Moodie et al., 2007; Robins et al., 2008; Brinkley et al., 2009; Zhao et al., 2009; Henderson et al., 2010; Orellana
et al., 2010; Gunter et al., 2011). Much of this work involves postulating a model for the regression of outcome on
treatment assignment and covariates, and then inferring from the model the best treatment assignment given patient
covariates. Zhang et al. (2012a,b) proposed a robust method that maximizes across all regimes in a prespecified
class a doubly robust augmented inverse probability weighted estimator (AIPWE) of the population mean outcome.
This method achieves comparable performance to methods based on direct outcome regression modeling and is more
robust to misspecification of regression models. With this method, as well as the recent inverse probability weighted
estimator of Zhao et al. (2012) and methods based on outcome regression, the parametric form of regimes has to be
pre-specified, either by practical considerations or through ad hoc preliminary data analysis.
In this article, we present a novel and general framework that facilitates flexible estimation of optimal treatment
regimes in the single decision point setting. Specifically, we recast the original problem of finding the optimal treat-
ment regime as a weighted classification problem and estimate the optimal treatment regime by estimating the Bayes
classifier, i.e., the one that minimizes the expected weighted misclassification error. This framework allows the esti-
mation of mean outcomes under a regime using any existing methods, e.g., regression estimator, inverse probability
weighted estimator (IPWE) or AIPWE, and is separated from the subsequent optimization for identifying the form of
treatment regimes, giving rise to its flexibility. Within this framework, the class of treatment regimes does not need
to prespecified and can instead be identified in a data-driven way by minimizing an expected weighted misclassifi-
cation error. Importantly, our approach allows for existing classification algorithms to be used without modification to
estimate an optimal treatment regime. This introduces a wealth of new and powerful learning algorithms for use in
estimating optimal treatment regimes.
The remainder of this paper is organized as follows. In Section 2, we formalize the problem of estimating the optimal
treatment regime using potential outcomes and review existing methods. In Section 3, we present a general classifica-
tion framework for identification of the optimal treatment regime. We conduct a small empirical study of the proposed
method in Section 4. We illustrate the proposed method using data from the National Adjuvant Breast and Bowel
Project (NSABP) in Section 5. Concluding remarks are made in Section 6.
2 Framework and methods
Consider a clinical trial or observational study where n subjects from a population of interest received one of two
treatment options, denoted by A D 0 or 1. Let Y denote the observed outcome of interest and, without loss of
generality, assume that larger values of Y are preferred. Let X denote the vector of patient characteristics collected
prior to treatment. The observed data are then .Xi, Ai, Yi/, i D 1, : : : , n, which are assumed to be independent and
identically distributed (i.i.d.) across i.
A treatment regime, g, is a map from the domain of X to the domain of A. The goal is to use the data to estimate
the optimal treatment regime, defined as the one that maximizes the expected outcome if used to assign treatments
to all patients in the population of interest. To precisely define and identify the optimal treatment regime, we adopt
the potential outcome framework (Rubin, 1978). Let Y.0/ and Y.1/ denote the potential outcomes for a subject
that would be observed had the subject received treatment 0 or 1, respectively. We assume that the actual observed
outcome is connected to the potential outcomes through Y D Y.1/A C Y.0/.1  A/; this is usually referred to as
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the consistency assumption and states that the observed outcome is the same as the potential outcome under the
treatment actually received. We assume that there is no interference among units, also known as the stable unit
treatment assumption (SUTVA). We further assume ¹Y.0/, Y.1/º ?? AjX, where ?? denotes statistical independence;
this states that there are no unmeasured confounders, and that treatment A, conditional on X, can be viewed as
being randomly assigned. In a randomized clinical trial, this assumption is trivially true. Under these assumptions, it
is straightforward to show that the overall population mean were all patients in the population to receive treatment a,
E¹Y.a/º, is equal to EX[ E¹YjA D a, Xº], where EX./ denotes expectation with respect to the marginal distribution of X.
Thus, for an arbitrary treatment regime g, the potential outcome for a subject randomly chosen from the population,
if he/she were to receive treatment according to g, can be defined as
Y.g/ D Y.1/g.X/C Y.0/¹1  g.X/º.
The optimal regime, gopt, is defined as the one yielding the largest value of E¹Y.g/º among the class of all potential
regimes, G; i.e., gopt D arg maxg2G E¹Y.g/º. Writing .a, X/ D E.YjA D a, X/, it is straightforward to show that
E¹Y.g/º D EX[.1, X/g.X/C .0, X/¹1  g.X/º] ,
and hence the optimal treatment regime is given by
gopt.X/ D I¹.1, X/ > .0, X/º.
An intuitive approach to estimating the optimal treatment regime, which we refer to as the regression method, is to
posit a parametric regression model for .A, X/ D E.YjA, X/, say .A, X;ˇ/. If the model is correctly specified, then
.A, X/ D .A, X;ˇ0/ for some ˇ0, and the optimal regime is therefore g.X,ˇ0/, where g.X,ˇ/ D I¹.1, X,ˇ/ >
.0, X,ˇ/º. Hence, it is natural to estimate the optimal treatment regime by Ogoptreg.X/ D I¹.1, X, Ǒ/ > .0, X, Ǒ/º, where
Ǒ is an estimator of ˇ. Clearly, if the model for .A, X/ is incorrectly specified, Ogoptreg.X/ may not be a good estimator of
gopt.X/.
Alternatively, a semiparametric version of the regression method, G-estimation (Robins, 2004), considers a semipara-
metric model for .A, X/, exploiting the fact that the optimal treatment regime gopt.X/ only depends on the contrast
function C.X/ D .1, X/  .0, X/ through gopt.X/ D I¹C.X/ > 0º. Specifically, G-estimation posits a semiparametric
model .A, X/ D h1.X/ C ACG.X; /, where  is a finite dimensional vector and h1.X/ is unspecified. The estima-
tor O for  can be found by solving appropriate estimating equations involving a known or estimated propensity
score .X/ D pr.A D 1jX/ (Robins, 2004; see also Schulte et al., 2012). The optimal treatment regime is estimated
by OgoptG .X/ D I¹CG.X; O / > 0º. Like Og
opt
reg.X/, the quality of the G-estimation estimator Og
opt
G .X/ depends on how close
CG.X; / is to the true contrast function.
Recognizing that the posited regression model may be misspecified, Zhang et al. (2012a) instead considered such
a posited regression model as a mechanism for defining a class of induced treatment regimes. They estimated the
optimal regime within a pre-specified class by directly maximizing a doubly robust AIPWE of the population mean
outcome across all regimes in the class. The class of regimes G, indexed by parameter , can be derived from a
regression model .A, X;ˇ/, in which case  is a many-to-one function of ˇ (see Zhang et al., 2012a, for details)
or directly specified as depending on a key subset of elements of X based on practical considerations. The value
opt D arg max E¹Y.g/º, g 2 G, defines the optimal regime in G, i.e., gopt .X/ D g.X, opt/, which equals gopt.X/ if
G contains gopt.X/ and, although not the same as gopt.X/ if gopt.X/ is not in G, is still of considerable interest when
we focus our attention on the feasible class G. For fixed , the AIPWE for E¹Y.g/º is given by
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where C D Ag.X, / C .1  A/¹1  g.X, /º, .X; / is a posited model for the propensity score .X/; O is the
maximum likelihood (ML) estimator for  ; c.X; , O/ D .X; O/g.X, / C ¹1  .X; O/º¹1  g.X, /º; m.X; ,ˇ/ D
.1, X,ˇ/g.X, /C.0, X,ˇ/¹1 g.X, /º is a model for E¹Y.g/jXº D .1, X/g.X, /C.0, X/¹1 g.X, /º; .A, X;ˇ/
is a model for E.YjA, X/; and Ǒ is an estimator for ˇ. Denoting the value that maximizes AIPWE./ by OoptAIPWE, which
estimates opt, one can then estimate gopt .X/ by Og
opt
,AIPWE.X/ D g.X, O
opt
AIPWE/.
As an alternative to the AIPWE estimator, Zhang et al. (2012a) also discussed the inverse probability weighted







The definitions of the estimators OoptIPWE and Og
opt
,IPWE.X/ based on IPWE./ follow immediately. The method of Zhao et
al. (2012) estimates the optimal treatment regime by maximizing a concave relaxation of the above IPWE estimator.
This relaxation is analogous to the use of surrogate or proxy loss functions in classification (see, for example, Hastie
et al., 2009); this relaxation provides numerical stability and facilitates efficient computation of the maximum.
3 Treatment regimes and classification
In this section, we describe a general framework for transforming the problem of estimating an optimal treatment
regime into weighted classification problem. Using the previous notation, we see that
E ¹Y.g/º D EX[.1, X/g.X/C .0, X/¹1  g.X/º]
D EX[ g.X/¹.1, X/  .0, X/º C .0, X/]
D E¹g.X/C.X/º C E¹.0, X/º,
so that gopt D arg maxg2G E¹Y.g/º D arg maxg2G E¹g.X/C.X/º. A natural strategy for estimating the optimal treat-
ment regime is to first construct an estimator OC for C using the observed data, and estimate gopt by Ogopt D
arg maxg2G n1
Pn
iD1 g.Xi/ OCi.Xi/. Next we will see that all of the estimators discussed in the preceding section can be
seen as following this approach.
The regression method posits a model E.YjA, X/ D .A, X;ˇ/, that defines the class of treatment regimes, Gˇ ,
indexed by ˇ, with elements of the form g.X,ˇ/ D I¹.1, X,ˇ/ > .0, X,ˇ/º. It then estimates gopt.x/ by
Ogoptreg.x/ D I¹.1, x, Ǒ/ > .0, x, Ǒ/º, which is equivalent to arg maxg2Gˇ n
1
Pn
iD1 g.Xi/ OCreg.Xi/, where OCreg.x/ D
.1, x, Ǒ/  .0, x, Ǒ/ is a regression estimator of C.x/.
G-estimation directly models the contrast function, which subsequently defines the class of treatment regimes, G ,
indexed by  , with elements of the form g.X, / D I¹CG.X, / > 0º. The resulting estimator Og
opt
G .x/ D I¹CG.x, O / > 0º
is thus equal to arg maxg2G n
1
Pn
iD1 g.Xi/ OCG.Xi/, where OCG.x/ D CG.x, O /.
The robust method in Zhang et al. (2012a) considers the a priori specified class of regimes G. The AIPWE for
E¹Y.g/º with a fixed  can be rewritten as
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1  .Xi, O/
.0, Xi, Ǒ/. (2)
The method of Zhang et al. (2012a) estimates gopt by Og
opt




iD1 g.Xi/ OCAIPWE.Xi/. Note that the AIPWE estimator of the contrast function borrows information
from, but is not completely determined by, the specified parametric regression model for the outcome. In contrast to
this, estimators of the contrast function using regression or G-estimation methods are completely determined by the
specified regression models, and the IPWE estimator given below makes no use of a regression model for the outcome
given covariates. The AIPWE contrast estimates strike a balance between the foregoing two extremes and this balance
partly explains the improved empirical performance in Section 4.
The inverse probability weighted estimator (IPWE) for E¹Y.g/º, is equivalent to estimating the contrast function at






1  .Xi, O/
Yi. (3)
Unlike other methods for estimating the contrast function, which either are completely determined by or incorporates
information from a semiparametric or parametric outcome regression model, the IPWE estimator of C.Xi/ for each
i is completely determined by the observed outcome, weighted by an estimated propensity. The IPWE estimates of
the contrast values may be too noisy to successfully inform the class of treatment regimes, as demonstrated by our
simulations.
From the above discussion, we see that estimating the optimal treatment regime in the class G or the restricted class
G can be separated into two steps: constructing an estimator OC.Xi/ of the contrast function C.Xi/ for i D 1, : : : , n, and
subsequently estimating gopt by Ogopt D arg max n1
Pn
iD1 g.Xi/ OC.Xi/, where the maximization is across all regimes in
the class considered. Note that in the regression and G-estimation methods, the class of regimes is dictated by either
.A, X;ˇ/ or CG.X; /; and the estimation of the contrast function and the maximization of the objective function are
carried out simultaneously by fitting the corresponding regression models. As a result, if the posited regression model,
.A, X;ˇ/ or CG.X; /, is correctly specified, the corresponding estimator of the contrast function is consistent; in such
a case the estimator of the optimal treatment regime is a consistent estimator of gopt, as Gˇ or G contains gopt. If
the posited model is misspecified, however, Ogoptreg or Og
opt
G may be far from the optimal treatment regime in G or even
the optimal regime in the corresponding restricted class Gˇ or G , and thus, may perform poorly. In contrast, in the
robust AIPWE-based method of Zhang et al. (2012), the estimation of the contrast function and the maximization of
the objective function across G are separated. An advantage of this separation is that even if G does not contain
gopt, the resulting estimator may still be the optimal one in G. In the method of Zhang et al. (2012a), the class of
treatment regimes under consideration, G, indexed by a finite-dimensional parameter, is either entirely determined
by the model for the outcomes Y or is pre-specified based on practical considerations. In practice, one can inform
the class of treatment regimes by using standard model building techniques for the regression model of outcome on
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treatment and patient characteristics. However, these model building techniques target identifying a good model for
the outcome, but not necessarily a high-quality treatment regime.
We now introduce a general framework that can address the issues discussed above. Specifically, the problem of
estimating the optimal treatment regime is reformulated as a weighted classification problem, where the optimal
treatment regime minimizes a weighted misclassification error.
Because C.X/ D I¹C.X/ > 0ºjC.X/j  I¹C.X/ 6 0ºjC.X/j, we can rewrite g.X/C.X/ as
g.X/C.X/ D g.X/I¹C.X/ > 0ºjC.X/j  g.X/I¹C.X/ 6 0ºjC.X/j
D I¹C.X/ > 0ºjC.X/j  jC.X/j[ ¹1  g.X/ºI¹C.X/ > 0º C g.X/I¹C.X/ 6 0º] .
As g.X/ takes values ¹0, 1º, it is easy to check that
¹1  g.X/ºI¹C.X/ > 0º C g.X/I¹C.X/ 6 0º D[ I¹C.X/ > 0º  g.X/]2 .
Combining these results, g.X/C.X/ can be rewritten as
g.X/C.X/ D I¹C.X/ > 0ºjC.X/j  jC.X/j[ I¹C.X/ > 0º  g.X/]2 .
Therefore, we can define the optimal treatment regime as






E[ I¹C.X/ > 0ºjC.X/j]E
®







jC.X/j[ I¹C.X/ > 0º  g.X/]2
¯
.
That is, the optimal treatment regime, gopt, is the one that minimizes E.jC.X/j[ I¹C.X/ > 0º  g.X/]2 /. This identity is
what allows us to recast the problem of estimating an optimal treatment regime as a weighted classification problem.
We view each subject as belonging to one of the two classes defined by Z D I¹C.X/ > 0º. That is, the class Z D 1
is composed of those subjects who would benefit more from treatment 1 compared to treatment 0; i.e., those who
have .1, X/ > .0, X/, and should therefore be treated with treatment option 1. Each subject is also given a weight
W D jC.X/j, which represents the loss that would be incurred if the subject were misclassified. In this way, we separate
the information contained in C.X/ into two parts: the class label Z, containing the information about the sign of C.X/;
and the weight W, containing the information about the magnitude of C.X/. Hence, E.jC.X/j[ I¹C.X/ > 0º  g.X/]2 /
can be regarded as the expected weighted misclassification error under the classification rule g.X/.
In practice, the contrast function C.X/ and hence the class label Z and weight W for each subject are not available in
the observed data. As discussed previously, the contrast values C.Xi/ for each i can be estimated from the data, for
example, using OCreg, OCG, OCIPWE, or OCAIPWE. Once the estimates OC.Xi/, i D 1, : : : , n, are obtained, we can construct a
class label OZi D I¹ OC.Xi/ > 0º, and a weight OWi D j OC.Xi/j for each subject, and gopt can be estimated subsequently by
arg ming2G
Pn
iD1[ OWi¹OZi  g.Xi/º
2]. The minimization of
Pn
iD1[ OWi¹OZi  g.Xi/º
2] can then be viewed as a typical classi-
fication problem with OZi as the binary “response,” Xi as the “predictor,” OWi as the “weight,” and g is the “classification
rule.” By reformulating the problem of estimating the optimal treatment regime as a classification problem, existing
classification techniques can be used, for example, classification and regression trees (CART, Breiman et al., 1984)
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or support vector machines (SVM, Cortes and Vapnik, 1995), to minimize the classification error across a broad class
of regimes. Therefore, the parametric form of treatment regimes does not need to be pre-specified and instead can be
selected using classification techniques.
We comment that the method of Zhao et al. (2012) can be viewed as a special case within our framework, with
the contrast function at each of the observed data points estimated by the IPWE estimator OCIPWE.Xi/. To see this,
it is straightforward to show that, corresponding to the IPWE estimator of the contrast function, the class label











Ai.Xi, O/C .1  Ai/¹1  .Xi, O/º
.








Ai.Xi, O/C .1  Ai/¹1  .Xi, O/º
I¹Ai ¤ g.Xi/º,
which is exactly the approximated weighted classification error used by Zhao et al. (2012). Zhao et al. (2012)
minimize the above weighted classification error using support vector machines. The method of Zhao et al. (2012) is
predicated on an IPWE estimator of the expected outcome. However, the classification framework we propose is more
general and allows estimation of the contrast function by any method, e.g., the AIPWE, as well as the data-driven
selection of the class of treatment regimes using the estimated class labels and observation weights.
In the proposed classification framework, we disentangle two critical steps: (i) constructing a suitable estimator of
the contrast function, and (ii) finding estimated optimal treatment rules with an interpretable form using classification
techniques. This allows both greater flexibility in modeling the outcome or contrast functions and the ability to use any
classification technique to inform the class of treatment regimes. We comment that, in our framework, for each subject
there is a corresponding “weight” and “label,” which do not depend on a treatment regime. Therefore, exploratory
analysis and model diagnostics can be used in the classification step by a skilled data-analyst to build high-quality
scientifically defensible models. This added benefit, however, is not available in the classification method of Zhao et
al. (2012) or the previous work on robust estimation by Zhang et al. (2012a). Also, notice that with the classification
approach the interpretability of the final decision rule does not require a parsimonious estimator of the contrast
function. Consequently, we can use flexible models for the contrast function, e.g. support vector regression (Vapnik et
al., 1997), boosting (Freund & Schapire, 1997), etc., and still produce an interpretable decision rule. In addition, the
selection of the form of treatment regimes by classification techniques in the proposed framework is directly targeting
the problem of finding the optimal treatment regime by minimizing weighted misclassification error. In the next section,
for illustration of the proposed methods, we use classification and regression trees (CART) to produce interpretable
decision rules.
4 Simulation studies
To evaluate the performance of the proposed methods, we have carried out two simulation studies, each involving
1000 Monte Carlo data sets. For definiteness, we use CART to minimize the expected weighted misclassification;
other methods developed in the area of classification could also be used.
In the first scenario, for each data set, we generated n D 200, 500, and 1000 observations .Yi, Ai, Xi/, i D 1, : : : , n,
where Xi D .Xi1, : : : , Xi5/T and Xi1, : : : , Xi5 were independent standard normal; given Xi, Ai was Bernoulli with success
probability satisfying logit¹pr.A D 1jX/º D 0.1 C 0.5X1 C 0.5X2, logit.u/ D log¹u=.1  u/º; and outcomes were
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generated as Yi D .Ai, Xi/C i for i standard normal and .A, X/ D exp¹2.0C 0.25X1 C 0.25X2  0.25X5  0.5.a 
gopt.X//2º, where gopt.X/ D I.X1 > 0.545/I.X2 < 0.545/.
For the proposed methods, to estimate the contrast function C.X/, we considered the regression estimator OCreg, the
AIPWE estimator OCAIPWE, and the IPWE estimator OCIPWE. We considered a working regression model .A, X;ˇ/ D
ˇ0Cˇ1X1Cˇ2X2Cˇ3X3Cˇ4X4Cˇ5X5CA.ˇ6Cˇ7X1Cˇ8X2Cˇ9X3Cˇ10X4Cˇ11X5/, which is misspecified, and
estimated ˇ D .ˇ1, : : : ,ˇ11/ in the model using least squares. We considered both a correctly specified propensity
model .X; / D expit.0C1X1C2X2/, and an incorrectly specified model .X; / D  ; these models were fit using
ML. Note that when the propensity model is constant, OCreg and OCG are equivalent, thus we omit OCG.
Once we obtained the estimated contrast function for each subject, e.g., OCAIPWE.Xi, Ai, Yi; O , Ǒ/, we defined the binary
responses, e.g., OZi D I¹ OCAIPWE.Xi, Ai, Yi; O , Ǒ/ > 0º, and the case weights, e.g., OWi D j OCAIPWE.Xi, Ai, Yi; O , Ǒ/j for each
subject, so that the classification dataset becomes ¹OZi, Xi, OWiº. We input this new data set into the CART algorithm to
find the estimated optimal treatment regime. We used the R function rpart with default settings, except that we set
the weights as the estimated weight OW.
For the second scenario, the data generation was the same as in the first scenario except that gopt.X/ D I.X1 > X2/.
Note that here, in contrast to the first scenario, the class of treatment regimes with simple tree form does not contain
gopt. Thus, this scenario examines whether or not CART can find a regime close to the optimal treatment regime gopt.
We also estimated the optimal treatment regime using the usual regression (RG) method which models .A, X;ˇ/ and
the robust AIPWE-based method of Zhang et al. (2012a) which involves modeling both .A, X;ˇ/ and propensities;
models for .A, X;ˇ/ and propensities are as those used in the proposed methods. In the method of Zhang et al.
(2012a), we consider optimizing over the class of treatment regimes defined by the outcome regression model, i.e.,
G D ¹I.ˇ6 C ˇ7X1 C ˇ8X2 C ˇ9X3 C ˇ10X4 C ˇ11X5 > 0/º.
Table I. Results for the first simulation scenario using 1000 Monte Carlo data sets. E¹Y.gopt/º D
8.12. OE.Ogopt/ shows the Monte Carlo average and standard deviation of estimated values of the true
E.Ogopt/ using (1). E.Ogopt/ shows the Monte Carlo average and standard deviation of values E¹Y.Ogopt/º
obtained using 106 Monte Carlo simulations for each data set. PS correct and PS incorrect indicate
whether the specified propensity score model is correct or not.
n=200 n=500 n=1000
Estimator OE.Ogopt/ E.Ogopt/ OE.Ogopt/ E.Ogopt/ OE.Ogopt/ E.Ogopt/
PS correct
RG 7.56 (0.35) 7.49 (0.08) 7.56 (0.21) 7.53 (0.05) 7.55 (0.16) 7.54 (0.04)
Zhang et al. 7.83 (0.37) 7.53 (0.08) 7.76 (0.22) 7.59 (0.06) 7.73 (0.17) 7.62 (0.04)
OCAIPWE 8.08 (0.37) 8.07 (0.06) 8.10 (0.22) 8.11 (0.02) 8.11 (0.16) 8.12 (0.01)
OCIPWE 7.18 (0.53) 7.02 (0.42) 7.66 (0.40) 7.57 (0.38) 7.93 (0.26) 7.90 (0.22)
OCreg 7.51 (0.36) 7.43 (0.18) 7.52 (0.23) 7.49 (0.10) 7.52 (0.17) 7.50 (0.08)
PS incorrect
RG 7.50 (0.30) 7.49 (0.08) 7.50 (0.18) 7.53 (0.05) 7.50 (0.13) 7.54 (0.04)
Zhang et al. 7.68 (0.30) 7.52 (0.09) 7.62 (0.19) 7.57 (0.06) 7.59 (0.14) 7.59 (0.05)
OCAIPWE 7.95 (0.31) 8.08 (0.04) 7.98 (0.19) 8.11 (0.02) 7.99 (0.14) 8.12 (0.01)
OCIPWE 6.98 (0.34) 6.93 (0.25) 7.08 (0.22) 7.04 (0.16) 7.12 (0.16) 7.08 (0.12)
OCreg 7.44 (0.31) 7.43 (0.18) 7.45 (0.20) 7.49 (0.10) 7.44 (0.14) 7.50 (0.08)
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Table II. Results for the second simulation scenario using 1000 Monte Carlo data sets. E¹Y.gopt/º D
8.12. Entries as Table I.
n=200 n=500 n=1000
Estimator OE.Ogopt/ E.Ogopt/ OE.Ogopt/ E.Ogopt/ OE.Ogopt/ E.Ogopt/
PS correct
RG 7.82 (0.32) 7.78 (0.13) 7.84 (0.21) 7.83 (0.10) 7.85 (0.16) 7.84 (0.08)
Zhang et al. 8.09 (0.32) 8.01 (0.08) 8.11 (0.20) 8.07 (0.03) 8.11 (0.15) 8.09 (0.02)
OCAIPWE 7.96 (0.33) 7.68 (0.13) 8.03 (0.20) 7.83 (0.06) 8.04 (0.15) 7.89 (0.04)
OCIPWE 7.11 (0.41) 6.96 (0.31) 7.39 (0.28) 7.28 (0.23) 7.55 (0.22) 7.47 (0.17)
OCreg 7.67 (0.34) 7.57 (0.17) 7.73 (0.21) 7.68 (0.11) 7.73 (0.16) 7.70 (0.08)
PS incorrect
RG 7.79 (0.30) 7.78 (0.13) 7.82 (0.19) 7.83 (0.10) 7.82 (0.14) 7.84 (0.08)
Zhang et al. 8.01 (0.30) 8.02 (0.06) 8.03 (0.18) 8.07 (0.03) 8.03 (0.14) 8.09 (0.02)
OCAIPWE 7.87 (0.30) 7.70 (0.11) 7.95 (0.18) 7.85 (0.05) 7.96 (0.13) 7.89 (0.04)
OCIPWE 7.11 (0.37) 7.09 (0.26) 7.22 (0.24) 7.19 (0.16) 7.25 (0.18) 7.22 (0.12)
OCreg 7.63 (0.31) 7.57 (0.17) 7.70 (0.20) 7.68 (0.11) 7.70 (0.15) 7.70 (0.08)
Results for the two scenarios are shown in Tables I and II, respectively. Under scenario 1 (Table I) where the true
gopt is in the form of a tree, it is clear that the proposed method using the AIPWE estimator of the contrast function,
i.e., OCAIPWE, achieves the best performance overall, with expected outcomes under the chosen regimes very close to
the expectation under the true optimal regime. This good performance, we believe, is for two reasons. First, OCAIPWE
estimates the contrast function using the AIPWE, which, as discussed previously, is robust and efficient relative to
competing methods. Second, it exploits a flexible classification method for optimization, without having to prespecify
the parametric form of the class of regimes under consideration. All other methods lack either one or both of these two
features. We note that OCIPWE has the worst performance of the considered methods across all scenarios, which may be
due to instability of the IPWE. Under scenario 2 (shown in Table II) the true gopt is linear and not well-approximated
by a tree with splits along the coordinate axes; the method of Zhang et al. (2012a) has the best performance, which
is expected since the specified class G contains the true optimal regime. Nevertheless, the proposed method using
OCAIPWE estimates regimes with near optimal performance.
5 Application to the NSABP trial
As an illustration, consider data from a trial conducted by the National Surgical Adjuvant Breast and Bowel Project
(NSABP) comparing L-phenylalanine mustard and 5-fluorouracil (PF) to PF plus tamoxifen (PFT) in patients with pri-
mary operable breast cancer and positive nodes (Fisher et al., 1983). The study investigators found that heterogeneity
in response to PFT exists and the response depends on age (years) and progesterone receptor level (PR, fmol). Gail
& Simon (1985) analyzed these data using a test for qualitative interaction between treatment and covariates. Their
results support the regime proposed by Fisher et al. (1983), which recommends that subjects with age < 50 and PR
< 10 fmol should receive PF, with all others receiving PFT.
We analyzed data from n D 1276 patients with complete information on age and PR. Because the distribution of PR
is very skewed, following Zhang et al. (2012a), we make the log transformation, i.e., LPR D log.PRC 1/. We denote
age and LPR by X1 and X2, respectively. The outcome of interest is binary with Y D 1 if a subject survived disease-free
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to three years from baseline, and Y D 0 otherwise. Indicator variable A denotes treatment with A D 1 if a subject was
randomized to PFT and 0 if PF.
We implemented the proposed method using the AIPWE estimator of the contrast function and CART for the clas-
sification step. The simple form of a decision tree yielded from CART allow us to make direct comparison with
the regime of Fisher et al. (1983) and Gail & Simon (1985). To calculate OCAIPWE.X, A, Y; O , Ǒ/, one needs to
build both outcome regression and propensity score models. For the outcome regression, we postulated the logistic
regression model
.A, X;ˇ/ D expit¹ˇ0 C ˇ1X1 C ˇ2X2 C A.ˇ3 C ˇ4X1 C ˇ5X2/º (4)
for E.YjA, X/ D pr.Y D 1jA, X/, where expit.u/ D eu=.1 C eu/. The propensity score .X/ was estimated directly
by the sample proportion i.e.,
Pn
iD1 Ai=n for all X, as this was a randomized study. Constructing weights and labels
based on the estimated contrasts, the estimated optimal treatment regime given by CART is OgoptC,AIPWE.X/ D 1 I.age <
59.5 and PR < 16.5/, under which a patient should receive PF if she is younger than 59.5 and has PR less than 16.5
and should receive PFT otherwise. Note that the estimated regime has the same form as that of Fisher et al. (1983)
and Gail & Simon (1985) but differs a bit in the cutoff values. The estimated mean outcomes using (1) under the
estimated regime is 0.681 .95%CI : 0.646, 0.717/.
Considering a restricted class of regimes with a form 1  I.age < 1 and PR < 2/, the robust AIPWE-based method
of Zhang et al. (2012a) yields an estimated regime given by 1  I.age < 60 and PR < 9/, with estimated mean
outcomes under the regime 0.686 .0.651, 0.722/. The results are virtually identical as in our methods. However, in
the method of Zhang et al. (2012a), the form of regime has to be determined a priori, which can be challenging
in practice.
6 Discussion
We proposed a novel framework within which the optimal treatment regime at a single decision point can be estimated
using off-the-shelf classification methods. This framework allows the separation of two critical steps. In the first step,
estimated contrast functions are constructed for each subject independently without the need to specify a class of
treatment regimes. Based on the estimated contrasts, a “weight” and a binary “response” are created for each subject
which are then used as input to a classification algorithm to identify the optimal treatment regime by minimizing a
weighted misclassfication error. This separation creates flexibility and allows the use of existing classification algorithms
on this new class of problems. As in Zhang et al. (2012a), the class of treatment regimes does not have to be dictated
by a regression model for the outcome and can therefore be more robust and flexible.
The proposed framework is general enough to include both the work of Zhao et al. (2012), and Zhang et al. (2012a)
as special cases. Nonetheless, there are a number of interesting directions for future research; we mention two that are
of particular interest. The first is the incorporation of variable selection methods both in the modeling of the contrast
function (say, through the outcome regression model) and the subsequent classification algorithm. One approach
would be to perform model selection separately for the estimation of the contrast function and the estimation of the
optimal treatment regime. However, in high dimensions, the selected outcome regression model may have a significant
impact on the quality of the estimated optimal treatment regime, and it is preferable that the two model selection
steps be done in concert. A second direction is to extend this framework to include the multiple decision setting. In
this setting, personalized treatment is operationalized as sequence of treatment regimes, one for each stage of clinical
intervention, that adapt to the patients evolving health status. Zhang et al. (2012b) derive an AIPWE method for
estimating an optimal sequence of treatment regimes but a general framework is lacking.
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